Health-related workplace absenteeism may provide additional information about the extent of influenza sickness in the working-age population, a CDC report said.
Workplace absenteeism is an important supplementary measure of the flu's impact on adults of working age, according to a recent CDC report, which said the information can inform prevention messaging and pandemic preparedness planning.
Influenza morbidity is often not accurately reflected through current measures including surveillance and laboratory data, the report said, and the CDC’s National Institute for Occupational Safety and Health’s (NIOSH) monitoring of health-related workplace absenteeism can show additional effects. The report was conducted during the 2017 to 2018 high-severity influenza season using NIOSH’s data of the prevalence of health-related workplace absenteeism and from the Current Population Survey (CPS)—a monthly national survey of approximately 60,000 households conducted by the United States Census Bureau for the Bureau of Labor Statistics.
“During an influenza pandemic and during seasonal epidemics, more persons have symptomatic illness without seeking medical care than seek treatment at doctor’s offices, clinics, and hospitals,” the authors explained. “Consequently, surveillance based on mortality, health care encounters, and laboratory data does not reflect the full extent of influenza morbidity. CDC uses a mathematical model to estimate the total number of influenza illnesses in the United States.”
Health-related workplace absenteeism was defined as working less than 35 hours during a certain week due to the worker’s illness, injury, or other medical issue. During the high-severity influenza season, health-related workplace absenteeism among full-time workers was 1.7% in October 2017 and increased significantly beginning in November. The rate of absenteeism peaked in January 2018 at 3.0% and then steadily decreased to a low of 1.4% in July before increasing again in August and September.
The results of this report are consistent with other studies, as it has been previously recognized that health-related workplace absenteeism correlates with influenza-like illness. However, there are demographic characteristics that could impact the data, including vaccination coverage and access to sick leave.
“Surveillance of workplace absenteeism can provide an important supplementary measure of a pandemic’s impact because conventional morbidity and mortality statistics might not fully reflect the disruption caused to the social and economic life of the community,” concluded the report. “Workplace absenteeism is also one component of the World Health Organization’s Pandemic Influenza Severity Assessment impact indicator.”
The report suggests that state and local health authorities consider these results when developing targeted prevention messages and for monitoring long-term trends of influenza.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
August 31st 2021On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Listen
Retaining Health Care Workers Starts With Insights on “How We Can Stop Breaking Them”
March 2nd 2024Friday's keynote speaker, Katherine A. Meese, PhD, addressed the conference theme of workforce support at the Association of Cancer Care Centers 50th Annual Meeting and Cancer Center Business Summit.
Read More
Lowering Cardiometabolic Drug Costs May Improve Diabetes Health Outcomes
February 9th 2024Patients enrolled in a preventive drug list (PDL) benefit saw an 8.4% reduction in acute, preventable diabetes complication days, and PDL members residing in lower-income areas saw a 10.2% decrease compared with control members.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
August 31st 2021On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Listen
Retaining Health Care Workers Starts With Insights on “How We Can Stop Breaking Them”
March 2nd 2024Friday's keynote speaker, Katherine A. Meese, PhD, addressed the conference theme of workforce support at the Association of Cancer Care Centers 50th Annual Meeting and Cancer Center Business Summit.
Read More
Lowering Cardiometabolic Drug Costs May Improve Diabetes Health Outcomes
February 9th 2024Patients enrolled in a preventive drug list (PDL) benefit saw an 8.4% reduction in acute, preventable diabetes complication days, and PDL members residing in lower-income areas saw a 10.2% decrease compared with control members.
Read More
2 Commerce Drive
Cranbury, NJ 08512